Concert Pharmaceuticals (CNCE) PT Lowered to $26 at Mizuho Securities

November 1, 2018 11:17 AM EDT Send to a Friend
Mizuho Securities analyst Didei Yang lowered the price target on Concert Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login